Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Companies Business US: News
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Danone SA Food and drink Economy
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Health & Science Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Breaking News: Business Business News Pharmaceuticals
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Companies US: News Business
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags Investment strategy Economy Prices
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Markets Investing Jack in the Box Inc
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
Tags Europe News Biotech and Pharmaceuticals Europe Markets
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Eli Lilly and Co AstraZeneca PLC Biotech and Pharmaceuticals
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
Tags Enterprise Business News Media
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Eli Lilly and Co Stock Picks Business
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Trade Novartis AG Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Vertex Pharmaceuticals Inc Amgen Inc Sanofi SA
From CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
Tags Novo Nordisk A/S Breaking News: Europe Europe News
From CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
Tags Health & Science Biotech and Pharmaceuticals Hinge Health Inc
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
Tags Markets Novo Nordisk A/S Technology
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags US: News Business Companies
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Regeneron Pharmaceuticals Inc Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Pharmaceuticals Health care industry Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Health care industry Novo Nordisk A/S Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Healthy Returns LILLY DRN Social issues
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Markets Investing Novo Nordisk A/S
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Biotech and Pharmaceuticals Health & Science Companies
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Novo Nordisk A/S Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Novo Nordisk A/S Health insurance Health care industry
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback